BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohn JA, Kowalik CG, Kaufman MR, Reynolds WS, Milam DF, Dmochowski RR. Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction. Expert Rev Med Devices 2017;14:3-14. [PMID: 27915486 DOI: 10.1080/17434440.2017.1268913] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Osborne PB. Stimulating bioelectronic medicine discovery for urological disorders. Am J Physiol Renal Physiol 2017;313:F1133-5. [PMID: 28814439 DOI: 10.1152/ajprenal.00372.2017] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Jaqua K, Powell CR. Where Are We Headed with Neuromodulation for Overactive Bladder? Curr Urol Rep 2017;18. [DOI: 10.1007/s11934-017-0711-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Zhang Y, Meng L, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder. Transl Androl Urol 2021;10:1966-75. [PMID: 34159077 DOI: 10.21037/tau-21-43] [Reference Citation Analysis]
4 De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S, Van Kerrebroeck PEV. New Technologies and Applications in Sacral Neuromodulation: An Update. Adv Ther 2020;37:637-43. [PMID: 31875299 DOI: 10.1007/s12325-019-01205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
5 Pauwels N, Willemse C, Hellemans S, Komen N, Van den Broeck S, Roenen J, Van Aggelpoel T, De Schepper H. The role of neuromodulation in chronic functional constipation: a systematic review. Acta Gastroenterol Belg 2021;84:467-76. [PMID: 34599572 DOI: 10.51821/84.3.012] [Reference Citation Analysis]
6 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin-Verbe M, Elneil S. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn 2018;37:S17-22. [PMID: 29336058 DOI: 10.1002/nau.23476] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hernandez-reynoso AG, Nandam S, O’brien JM, Kanneganti A, Cogan SF, Freeman DK, Romero-ortega MI. Miniature electroparticle-cuff for wireless peripheral neuromodulation. J Neural Eng 2019;16:046002. [DOI: 10.1088/1741-2552/ab1c36] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin‐verbe MA, Elneil S. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12‐month results from the RELAX‐OAB study. Neurourology and Urodynamics 2019;38:689-95. [DOI: 10.1002/nau.23892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
9 Kim Y, Ortega M, Von Bargen E. Updates in treating fecal incontinence in women. Curr Opin Obstet Gynecol 2020;32:461-7. [PMID: 32925257 DOI: 10.1097/GCO.0000000000000660] [Reference Citation Analysis]
10 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin-Verbe M, Elneil S. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn 2018;37:S9-S16. [PMID: 29315785 DOI: 10.1002/nau.23465] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Khastgir J. Antimuscarinic drug therapy for overactive bladder syndrome in the elderly - are the concerns justified? Expert Opin Pharmacother 2019;20:813-20. [PMID: 30724647 DOI: 10.1080/14656566.2019.1574749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Araklitis G, Baines G, da Silva AS, Robinson D, Cardozo L. Recent advances in managing overactive bladder. F1000Res 2020;9:F1000 Faculty Rev-1125. [PMID: 32968482 DOI: 10.12688/f1000research.26607.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]